Benralizumab
ATC R03DX10 · 10 markets · 21 records
US 4 records · 2 strengths
AU 4 records · 3 strengths
- 30 mginjectionFASENRA benralizumab 30 mg in 1 mL solution for injection prefilled syringeFASENRA PEN benralizumab 30 mg in 1 mL solution for injection prefilled pen
- 30 mg/1 mLinjectionFasenra Pen
Records without a stated strength · 1 Fasenra Pen
GB 2 records · 1 strengths
- 30 mg/1 mLinjectionFasenra 30mg/1ml solution for injection pre-filled pensFasenra 30mg/1ml solution for injection pre-filled syringes
CA 2 records · 1 strengths
- 30 mgliquidFASENRAFasenra Pen
SG 2 records · 1 strengths
- 30 mg/mLinjectionFASENRA SOLUTION FOR INJECTION 30MG/ML (AUTOINJECTOR PEN)FASENRA SOLUTION FOR INJECTION 30MG/ML (PRE-FILLED SYRINGE)
ES 2 records · 1 strengths
- 30 mginjectionFASENRA PRECARGADA
HK 2 records · 1 strengths
Records without a stated strength · 1 FASENRA SOLUTION FOR INJECTION IN PRE-FILLED PEN 30MG/1ML、FASENRA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 30MG/1ML
TW 1 records · 1 strengths
- 30 mginjectionFasenra solution for injection 30mg肺昇朗注射液劑30毫克
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 FASENRA
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 30 mg injection | FASENRA | FASENRA benralizumab 30 mg in 1 mL solution for injection prefilled syringe FASENRA PEN benralizumab 30 mg in 1 mL solution for injection prefilled pen | FASENRA PRECARGADA | Fasenra solution for injection 30mg 肺昇朗注射液劑30毫克 | |||||
| 30 mg/1 mL injection | Fasenra 30mg/1ml solution for injection pre-filled pens Fasenra 30mg/1ml solution for injection pre-filled syringes | Fasenra Pen | |||||||
| 30 mg liquid | FASENRA Fasenra Pen | ||||||||
| 30 mg/mL injection | FASENRA SOLUTION FOR INJECTION 30MG/ML (AUTOINJECTOR PEN) FASENRA SOLUTION FOR INJECTION 30MG/ML (PRE-FILLED SYRINGE) | ||||||||
| 10 mg/0.5 mL injection | Manufacturer: Catalent Indiana, LLC FASENRA | ||||||||
unknown | Fasenra Pen | FASENRA SOLUTION FOR INJECTION IN PRE-FILLED PEN 30MG/1ML FASENRA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 30MG/1ML | FASENRA |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in SG and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en SG que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 SG 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 SG 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.